Koglo
Home Device for Fluid Therapy for Cats and Dogs
Company Overview
Snapshot
Founded in January 2018 by Yotam Kaufman, Gilad Lavi, Shlomo Amiel, and Gilad Segev, Koglo operates with 1–10 employees. The company has secured funding across one round from one investor. Koglo's status changed to Non Active in August 2024, indicating it ceased to operate.
Business overview
Koglo developed EZXS, a home-use device designed to simplify and reduce stress associated with administering subcutaneous treatments to cats and dogs. The technology focuses on providing maximum safety for pets and minimizing stress for owners and caretakers by concealing the needle throughout the procedure and incorporating a safety mechanism. Koglo operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices industry and pet owners globally.
Log in to access full profile ›Company Intelligence Q&A
- What is Koglo's primary product?
- Koglo's primary product is EZXS, a home device designed to facilitate subcutaneous fluid therapy for cats and dogs, aiming to make the process safer and less stressful for pets and their owners.
- When was Koglo founded?
- Koglo was founded in January 2018.
- Who are the founders of Koglo?
- The founders of Koglo are Yotam Kaufman, Gilad Lavi, Shlomo Amiel, and Gilad Segev.
- What is the current operational status of Koglo?
- Koglo became Non Active in August 2024, indicating that the company ceased to operate.
- Which sector does Koglo primarily operate in?
- Koglo primarily operates in the Health Tech & Life Sciences sector, focusing on medical devices for veterinary care.